#biotech
#biotech

23 hours ago

Health

Longevity enthusiast Bryan Johnson says he doesn't want to run his anti-aging company anymore

fromHarvard Gazette

2 weeks ago

Arts

Harvard novel explores love, immortality, and biotech - Harvard Gazette

NYC startup

Bay Area biotech company, once worth $1.2 billion, lays off almost entire staff

Marketing tech

Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views

Medicine

Bay Area biotech firm guts staff, shuts trial after dangerous side effects

7 months ago

Business

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Startup companies

Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut

Healthcare

This Former Meme Stock, Down 93%, is a High-Upside Buy Right Now

NYC startup

Bay Area biotech company, once worth $1.2 billion, lays off almost entire staff

Marketing tech

Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views

Medicine

Bay Area biotech firm guts staff, shuts trial after dangerous side effects

7 months ago

Business

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Startup companies

Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut

Healthcare

This Former Meme Stock, Down 93%, is a High-Upside Buy Right Now

European startups

China is catching up to the U.S. in pharmaceuticals, but it's not too late to turn that around

Health

Bay Area biotech company lays off half of staff after bungling drug batch

European startups

China is catching up to the U.S. in pharmaceuticals, but it's not too late to turn that around

Health

Bay Area biotech company lays off half of staff after bungling drug batch

more#drug-development

NIH funding uncertainty spurs new biotech venture fund | TechCrunch

The Trump administration's funding restrictions could limit grants to biotech startups, prompting the launch of a new pre-seed venture fund.

Barcelona's Zymvol secures 3M: CEO Maria Fatima Lucas on democratising enzyme development, market expansion, and more - Silicon Canals

Zymvol secured â¬3M in seed funding to enhance its enzyme engineering technology and expand its market presence.

NYC startup

Elizabeth Holmes' partner reportedly fundraising for new blood-testing startup | TechCrunch

Bicycling

$1.8 billion fund is gobbling up Bay Area biotech 'zombies' for cheap

Venture

NIH funding uncertainty spurs new biotech venture fund | TechCrunch

The Trump administration's funding restrictions could limit grants to biotech startups, prompting the launch of a new pre-seed venture fund.

Barcelona's Zymvol secures 3M: CEO Maria Fatima Lucas on democratising enzyme development, market expansion, and more - Silicon Canals

Zymvol secured â¬3M in seed funding to enhance its enzyme engineering technology and expand its market presence.

NYC startup

Elizabeth Holmes' partner reportedly fundraising for new blood-testing startup | TechCrunch

Bicycling

$1.8 billion fund is gobbling up Bay Area biotech 'zombies' for cheap

Dutch biotech startup Cortalix secures 1M

Cortalix, a Dutch biotech startup, raised â¬1M to advance its nanobody technology for PET imaging and cancer therapies.

fromMedCity News

How Can Startups Navigate the Difficult Funding Environment - MedCity News

The current funding environment is challenging for startups and investors, forcing a need for creative capital solutions.

Miscellaneous

6 months ago

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

Verdiva has raised $410 million to develop oral drugs for obesity, challenging established players by addressing unmet medical needs in weight loss.

9 months ago

OMG science

French biotech Generare speeds up hunt for new drugs by cloning natural molecules | TechCrunch

London startup

Mews leads top 10 funding rounds in rough quarter for Dutch tech

Startup companies

Mosanna Therapeutics raises 70.1M to disrupt sleep apnea treatment with nasal spray - Silicon Canals

Dutch biotech startup Cortalix secures 1M

Cortalix, a Dutch biotech startup, raised â¬1M to advance its nanobody technology for PET imaging and cancer therapies.

fromMedCity News

How Can Startups Navigate the Difficult Funding Environment - MedCity News

The current funding environment is challenging for startups and investors, forcing a need for creative capital solutions.

Miscellaneous

6 months ago

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

Verdiva has raised $410 million to develop oral drugs for obesity, challenging established players by addressing unmet medical needs in weight loss.

9 months ago

OMG science

French biotech Generare speeds up hunt for new drugs by cloning natural molecules | TechCrunch

London startup

Mews leads top 10 funding rounds in rough quarter for Dutch tech

Startup companies

Mosanna Therapeutics raises 70.1M to disrupt sleep apnea treatment with nasal spray - Silicon Canals

23andMe is filing for bankruptcy. Here's what it means for your genetic data

23andMe has filed for bankruptcy amidst financial struggles and concerns over user data privacy.

Bay Area tech CEO resigns to bid for own flailing company

23andMe declared bankruptcy in Missouri court, reflecting its financial turmoil and struggles to maintain operations after a major data breach.

Health

fromNature

What went wrong at 23andMe? Why the genetic-data giant risks collapse

23andMe faces severe struggles, raising concerns about consumer genetic data and the future of the industry.

EU data protection

These are the 10 questions Congress has for 23andMe amid its bankruptcy sale

fromwww.cbc.ca

Privacy professionals

Non-profit run by 23andMe co-founder gets court approval to buy the genetic testing company | CBC News

US news

fromwww.npr.org

23andMe is filing for bankruptcy. Here's what it means for your genetic data

23andMe has filed for bankruptcy amidst financial struggles and concerns over user data privacy.

Bay Area tech CEO resigns to bid for own flailing company

23andMe declared bankruptcy in Missouri court, reflecting its financial turmoil and struggles to maintain operations after a major data breach.

Health

fromNature

What went wrong at 23andMe? Why the genetic-data giant risks collapse

23andMe faces severe struggles, raising concerns about consumer genetic data and the future of the industry.

EU data protection

These are the 10 questions Congress has for 23andMe amid its bankruptcy sale

fromwww.cbc.ca

Privacy professionals

Non-profit run by 23andMe co-founder gets court approval to buy the genetic testing company | CBC News

Vijay Pande, founding partner of a16z bio and health strategy, steps down | TechCrunch

Vijay Pande is stepping down from his role at a16z Bio+ Health, which is seeking a smaller $750 million fifth fund.

OMG science

Luxembourg's Exobiosphere raises 2M to accelerate drug discovery in space; here's why and how - Silicon Canals

fromAlleywatch

Venture

The Weekly Notable Startup Funding Report: 6/30/25

Silicon Valley

Vijay Pande, founding partner of a16z bio and health strategy, steps down | TechCrunch

Vijay Pande is stepping down from his role at a16z Bio+ Health, which is seeking a smaller $750 million fifth fund.

OMG science

Luxembourg's Exobiosphere raises 2M to accelerate drug discovery in space; here's why and how - Silicon Canals

fromAlleywatch

Venture

The Weekly Notable Startup Funding Report: 6/30/25

Exclusive | New home test can detect cancer - thanks to adorable puppies who sniff it out at lab

SpotItEarly combines trained dogs and AI to create an innovative at-home cancer screening test.

Growth hacking

How one biotech company sold over 500,000 AI-powered health testing kits without cutting corners on science

fromNew York Post

Exclusive | New home test can detect cancer - thanks to adorable puppies who sniff it out at lab

SpotItEarly combines trained dogs and AI to create an innovative at-home cancer screening test.

Growth hacking

How one biotech company sold over 500,000 AI-powered health testing kits without cutting corners on science

more#at-home-testing

It took me almost 18 months to switch careers, and I don't know if I'd do it again

At the end of September 2023, I quit my job. For the first few weeks, I relaxed and saw some friends. After that, I started my deep dive into the application process.

Miscellaneous

Dutch-based Leyden Labs secures 20M from EIB

Leyden Laboratories secures €20M funding to enhance pandemic preparedness through innovative antiviral research.

The focus is on developing non-vaccine therapies for respiratory viruses, specifically a nasal spray targeting influenza.

philosophy

fromThe Conversation

If it looks like a dire wolf, is it a dire wolf? How to define a species is a scientific and philosophical question

Colossal Biosciences' claims about restoring the dire wolf spark debate about species identity and the ethics of de-extinction.

How automotive exec Crystal Brown founded CircNova, an AI drug discovery biotech | TechCrunch

CircNova raises $3.3 million to develop AI-driven therapies targeting circular RNA for previously untreatable conditions.

Silicon Valley

Elon Musk's Neuralink raises $600M at $9B valuation | TechCrunch

Venture

How automotive exec Crystal Brown founded CircNova, an AI drug discovery biotech | TechCrunch

CircNova raises $3.3 million to develop AI-driven therapies targeting circular RNA for previously untreatable conditions.

Silicon Valley

Elon Musk's Neuralink raises $600M at $9B valuation | TechCrunch

Neuralink raised $600 million in funding, increasing its valuation to $9 billion pre-money.

Bay Area biotech company once worth $2B guts staff, departing execs get $600K

Sutro Biopharma faces drastic staff reductions and shifts in leadership due to ongoing financial losses.

Startup companies

Mass. biotech company cuts 90% of workforce

Silicon Valley

Bay Area biotech company lays off staff over sudden Trump administration order

NYC startup

Bay Area biotech firm once worth more than $4B lays off 30% of staff

NYC startup

Bay Area biotech company lays off staff, blaming Trump admin's funding cuts

NYC startup

Pharma company announces it will lay off 83 Boston-area employees

Bay Area biotech company once worth $2B guts staff, departing execs get $600K

Sutro Biopharma faces drastic staff reductions and shifts in leadership due to ongoing financial losses.

Startup companies

Mass. biotech company cuts 90% of workforce

Silicon Valley

Bay Area biotech company lays off staff over sudden Trump administration order

NYC startup

Bay Area biotech firm once worth more than $4B lays off 30% of staff

NYC startup

Bay Area biotech company lays off staff, blaming Trump admin's funding cuts

NYC startup

Pharma company announces it will lay off 83 Boston-area employees

Amsterdam's biotech firm Photanol files for bankruptcy

Photanol BV has filed for bankruptcy due to financing challenges, halting its promising CO2-to-chemical technology.

NYC startup

Bay Area biotech company, after raising $392M, forced into bankruptcy

Amsterdam's biotech firm Photanol files for bankruptcy

Photanol BV has filed for bankruptcy due to financing challenges, halting its promising CO2-to-chemical technology.

Intellectual property law

NYC startup

Bay Area biotech company, after raising $392M, forced into bankruptcy

more#bankruptcy

fromIPWatchdog.com | Patents & Intellectual Property Law

Pharma Playbook: What Practitioners Can Learn from Early UPC Litigation

The Unified Patent Court (UPC) is now central to pharmaceutical patent disputes in Europe, affecting strategies for innovators and generics.

EPO oppositions significantly impact UPC proceedings, influencing both patent validity and injunctive relief.

fromNew York Post

Theranos felon Elizabeth Holmes advising baby-daddy on new blood-testing startup from behind bars: report

Elizabeth Holmes supports her partner's new biotech startup while serving time for fraud related to Theranos.

fromBusiness Matters

Details Matter: The Life and Work of Donna Matuizek

I've always paid attention to details. That's where the truth is. That's where the mistakes hide.

OMG science

#clinical-trials

fromSilicon Valley Journals

A biotech company which developing therapies for orphan diseases raises $115M in funding

Glycomine raised $115 million to advance GLM101 into a Phase 2b clinical trial for PMM2-CDG.

Startup companies

SF biotech company, once worth nearly $1 billion, plans to shut down

fromSilicon Valley Journals

A biotech company which developing therapies for orphan diseases raises $115M in funding

Glycomine raised $115 million to advance GLM101 into a Phase 2b clinical trial for PMM2-CDG.

Startup companies

SF biotech company, once worth nearly $1 billion, plans to shut down

more#clinical-trials

fromsfist.com

April Fool's Day Around the Bay: Bob Lee's Family Has Sued His Convicted Killer Nima Momeni

Oakland's Grand Lake Theater has been recognized as one of the 21 Coolest Movie Theaters in the World by Variety, celebrating its nostalgic charm and traditional operations.

Silicon Valley real estate

Unleased lab space. Plunging valuations. Layoffs. In Massachusetts, the biotech slump is taking its toll.

The biotech sector faces significant challenges in 2023, undermining hopes for a rebound despite scientific advancements and interest rate drops.

fromwww.theguardian.com

AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing

AstraZeneca's $2.5 billion investment in Beijing aims to strengthen its research capabilities and move beyond recent controversies by fostering collaborations with local biotech companies.

European startups

Billionaire Healthcare Investor Alex Denner's Hedge Fund Has 75% of Its Assets in These 3 Stocks

Alex Denner's Sarissa Capital Management holds eight stocks, with three making up 75% of its portfolio.

Business intelligence

Biotechs Highlight 6 Stocks Insiders Are Buying Now

Insider buying in biotech companies signals potential growth for investors amid market uncertainty.

Venture

Bay Area biotech company that raised $66 million shuts down

Spotlight Therapeutics has closed down due to inadequate research outcomes and ongoing financial challenges.

fromwww.theguardian.com

Skinny jabs' are turning slimmers teetotal and drinks companies are feeling the loss

Wegovy users, like Hannah, report significant reductions in alcohol cravings and consumption, prompting analysts to predict a shift in market dynamics for the beverage industry.

Health